|
Imaging features
|
Sensitivity (95% CI)
|
Specificity (95% CI)
|
PPV (95% CI)
|
NPV (95% CI)
|
Az value (95% CI)
|
|---|
|
Head/neck location
|
47.4% (31.3–64.0%)
|
83.9% (65.5–93.9%)
|
78.3% (55.8–91.7%)
|
56.5% (41.2–70.8%)
|
0.656 (52.7–78.6%)
|
|
Lobulated shape
|
55.3% (38.5–71.0%)
|
87.1% (69.2–95.8%)
|
84.0% (63.1–94.7%)
|
61.3% (45.5–75.3%)
|
0.712 (58.9–83.5%)
|
|
Thin wall
|
76.3% (59.3–88.0%)
|
67.7% (48.5–82.7%)
|
74.4% (57.6–96.4%)
|
70.0% (50.4–84.6%)
|
0.720 (59.6–84.5%)
|
|
> 2 septa
|
71.1% (53.9–84.0%)
|
64.5% (45.4–80.2%)
|
71.1% (53.9–84.0%)
|
64.5% (45.3–80.2%)
|
0.678 (54.9–80.7%)
|
|
Two features
|
84.2% (68.1–93.4%)
|
80.6% (61.9–91.9%)
|
84.2% (68.1–93.4%)
|
80.6% (61.9–91.9%)
|
0.824 (71.9–93.0%)
|
|
Three features
|
55.3% (38.5–71.0%)
|
93.5% (77.2–98.9%)
|
91.3% (70.5–98.5%)
|
63.0% (47.5–76.4%)
|
0.744 (62.7–86.1%)
|
|
Four features
|
15.8% (6.6–31.9%)
|
100% (86.2–100%)
|
100% (51.7–100%)
|
49.2% (36.5–62.0%)
|
0.579 (44.5–71.3%)
|
- SCNs serous cystic neoplasms, PPV positive predictive value, NPV negative predictive value, CI confidence interval
